pH-Sensitive oral insulin delivery systems using Eudragit microspheres

References

• Jain D, Majumdar DK, Panda AK. (2006). Insulin loaded eudragit L100 microspheres for oral delivery: preliminary in vitro studies. J Biomater Appl, 21:195–211.
   PubMed Web of Science ®Google Scholar
• Takeuchi H, Yamamoto H, Niwa T, Hino T, Kawashima Y. (1996). Enteral absorption of insulin in rats from mucoadhesive chitosan-coated liposomes. Pharm Res, 13:896–901.
   PubMed Web of Science ®Google Scholar
• Huang L, Xin J, Guo Y, Li J. (2010). A novel insulin oral delivery system assisted by cationic β-cyclodextrin polymers. J App Polym Sci, 115, 1371–1379.
   Web of Science ®Google Scholar
• Makhlof A, Werle M, Tozuka Y, Takeuchi H. (2010). A mucoadhesive nanoparticulate system for the simultaneous delivery of macromolecules and permeation enhancer to the intestinal mucosa. J Control Rel (In press).
   PubMed Web of Science ®Google Scholar
• Paul W, Sharma CP. (2008). Tricalcium phosphate delayed release formulation for oral delivery of insulin: a proof-of-concept study. J Pharm Sci, 97:875–882.
   PubMed Web of Science ®Google Scholar
• Babu VR, Patel P, Mundargi RC, Rangaswamy V, Aminabhavi TM. (2008). Developments in polymeric devices for oral insulin delivery. Expert Opin Drug Deliv, 5:403–415.
   PubMed Web of Science ®Google Scholar
• Morishita M, Goto T, Nakamura K, Lowman AM, Takayama K, Peppas NA. (2006). Novel oral insulin delivery systems based on complexation polymer hydrogels: single and multiple administration studies in type 1 and 2 diabetic rats. J Control Release, 110:587–594.
   PubMed Web of Science ®Google Scholar
• Bai JP, Chang LL, Guo JH. (1995). Effects of polyacrylic polymers on the lumenal proteolysis of peptide drugs in the colon. J Pharm Sci, 84:1291–1294.
   PubMed Web of Science ®Google Scholar
• Tuesca A, Nakamura K, Morishita M, Joseph J, Peppas N, Lowman A. (2008). Complexation hydrogels for oral insulin delivery: effects of polymer dosing on in vivo efficacy. J Pharm Sci, 97:2607–2618.
   PubMed Web of Science ®Google Scholar
• Kumar A, Lahiri SS, Singh H. (2006). Development of PEGDMA: MAA based hydrogel microparticles for oral insulin delivery. Int J Pharm, 323:117–124.
   PubMed Web of Science ®Google Scholar
• Nakamura K, Murray RJ, Joseph JI, Peppas NA, Morishita M, Lowman AM. (2004). Oral insulin delivery using P(MAA-g-EG) hydrogels: effects of network morphology on insulin delivery characteristics. J Control Release, 95:589–599.
   PubMed Web of Science ®Google Scholar
• Gowthamarajan K, Kulkarni TG, Senthil RS, Suresh B. (2003). Microspheres as oral delivery system for insulin. Indian J Pharm Science, 65:177.
   Google Scholar
• Dave N, Hazra P, Khedkar A, Manjunath HS, Iyer H, Suryanarayanan S. (2008). Process and purification for manufacture of a modified insulin intended for oral delivery. J Chromatogr a, 1177:282–286.
   PubMed Web of Science ®Google Scholar
• Morishita I, Morishita M, Takayama K, Machida Y, Nagai T. (1992). Hypoglycemic effect of novel oral microspheres of insulin with protease inhibitor in normal and diabetic rats. Int J Pharm, 78:9–16.
   Web of Science ®Google Scholar
• Asada H, Douen T, Waki M, Adachi S, Fujita T, Yamamoto A et al. (1995). Absorption characteristics of chemically modified-insulin derivatives with various fatty acids in the small and large intestine. J Pharm Sci, 84:682–687.
   PubMed Web of Science ®Google Scholar
• Zhang N, Ping QN, Huang GH, Xu WF. (2005). Investigation of lectin-modified insulin liposomes as carriers for oral administration. Int J Pharm, 294:247–259.
   PubMed Web of Science ®Google Scholar
• Yu-Hsin Lin, Chiung-Tong Chen, Hsiang-Fa Liang Kulkarni, AR, Po-Wei Lee, Chun-Hung Chen, Hsing-Wen, Sung. (2007). Novel nanoparticles for oral insulin delivery via the paracellular pathway. Nanotechnology, 18:1–11.
   Google Scholar
• Yamagata T, Morishita M, Kavimandan NJ, Nakamura K, Fukuoka Y, Takayama K et al. (2006). Characterization of insulin protection properties of complexation hydrogels in gastric and intestinal enzyme fluids. J Control Release, 112:343–349.
   PubMed Web of Science ®Google Scholar
• Besheer A, Wood KM, Peppas NA, Mäder K. (2006). Loading and mobility of spin-labeled insulin in physiologically responsive complexation hydrogels intended for oral administration. J Control Release, 111:73–80.
   PubMed Web of Science ®Google Scholar
• Morishita M, Lowman AM, Takayama K, Nagai T, Peppas NA. (2002). Elucidation of the mechanism of incorporation of insulin in controlled release systems based on complexation polymers. J Control Release, 81:25–32.
   PubMed Web of Science ®Google Scholar
• Lowman AM, Morishita M, Kajita M, Nagai T, Peppas NA. (1999). Oral delivery of insulin using pH-responsive complexation gels. J Pharm Sci, 88:933–937.
   PubMed Web of Science ®Google Scholar
• Jiao YY, Ubrich N, Marchand-Arvier M, Vigneron C, Hoffman M, Maincent P. (2001). Preparation and characterization of heparin-loaded polymeric nanoparticles. Drug Del, 8:135–141.
   PubMed Web of Science ®Google Scholar
• Jiao YY, Ubrich N, Hoffart V, Marchand-Arvier M, Vigneron C, Hoffman M et al. (2002). Preparation and characterization of heparin-loaded polymeric microparticles. Drug Dev Ind Pharm, 28:1033–1041.
   PubMed Web of Science ®Google Scholar
• Attivi D, Werhlé P, Ubrich N, Damgé C, Hoffman M, Maincent P. 2005. Formulation of insulin-loaded polymeric nanoparticles using response surface methodology. Drug Dev Ind Pharm, 2:177–187.
   Google Scholar
• Mundargi RC, Babu VR, Rangaswamy V, Patel P, Aminabhavi TM. (2008). Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives. J Control Release, 125:193–209.
   PubMed Web of Science ®Google Scholar
• Hua QX, Weiss MA. (2004). Mechanism of insulin fibrillation: the structure of insulin under amyloidogenic conditions resembles a protein-folding intermediate. J Biol Chem, 279:21449–21460.
   PubMed Web of Science ®Google Scholar
• Agarwal V, Reddy IK, Khan MA. (2001). Polymethyacrylate based microparticulates of insulin for oral delivery: preparation and in vitro dissolution stability in the presence of enzyme inhibitors. Int J Pharm, 225:31–39.
   PubMed Web of Science ®Google Scholar
• Damgé C, Maincent P, Ubrich N. (2007). Oral delivery of insulin associated to polymeric nanoparticles in diabetic rats. J Control Release, 117:163–170.
   PubMed Web of Science ®Google Scholar
• Mundargi RC, Srirangarajan S, Agnihotri SA, Patil SA, Ravindra S, Setty SB et al. (2007). Development and evaluation of novel biodegradable microspheres based on poly(d,l-lactide-co-glycolide) and poly(epsilon-caprolactone) for controlled delivery of doxycycline in the treatment of human periodontal pocket: in vitro and in vivo studies. J Control Release, 119:59–68.
   PubMed Web of Science ®Google Scholar
• Prieto J, Wilmans M, Jiménez MA, Rico M, Serrano L. (1997). Non-native local interactions in protein folding and stability: introducing a helical tendency in the all beta-sheet alpha-spectrin SH3 domain. J Mol Biol, 268:760–778.
   PubMed Web of Science ®Google Scholar